SHOO · Steven Madden, Ltd. · Stock research

Current Thesis

The tariff-recovery trade in SHOO has stopped trending and turned into a range, and the range now has a hard edge: Q2 earnings land Thursday 2026-07-30 before the open. Since the failed marginal high at $47.11 in mid-June, the stock has traced a full round trip inside three weeks down to $39.71 on 2026-07-06, back to $43.75 by 2026-07-16. That is chop, not accumulation. What sits underneath it is a company whose reported growth is acquisition-fed (Kurt Geiger drove DTC +83.8% to $206.0M in Q1) and whose adjusted earnings are going the other way ($0.45 in Q1 2026 vs $0.60 a year prior, FY26 adjusted guide $2.00–$2.10). The sell-side has split into a bull camp pushing targets ($52 Needham, $54 Williams Trading, Zacks to Strong Buy on 2026-07-08) against a consensus average near $46.25 — that spot has already spent most of July flirting with. Insiders have been on one side of that debate the whole time: UBS flagged roughly $1.1M of insider sales over the trailing three months with zero offsetting purchases. Buying here is a bet on one print, priced without a discount.

Bullish and bearish views on Steven Madden, Ltd.

The model's bull view on Steven Madden, Ltd. (SHOO), in brief: The Q2 print is set up to beat the guide. The bear view: Adjusted earnings are shrinking while the multiple is not. Both cases follow in full.

Bull Case

• The Q2 print is set up to beat the guide. Williams Trading raised its target to $54 from $52 explicitly on the expectation that FY2026 guidance gets increased when Q2 is reported in late July. Zacks moved SHOO from Hold to Strong Buy on 2026-07-08. A guide-raise on 2026-07-30 is the single event that would resolve the range upward.
• Guidance already moved the right way once. On the Q1 call (2026-05-06) FY2026 revenue was lifted to +10–12% from +9–11%, with GAAP EPS $2.55–$2.65 and revenue framed around $2.8B. Management raising into a tariff backdrop is a different signal than management defending a number.
• The sourcing pivot is executed. China fell from 71% of US imports in 2024 toward roughly 30% currently, with CAFTA nearshoring plus Vietnam, Cambodia and Brazil absorbing the volume. The exposure that took the stock to $22.26 in the 2025 tariff crash has been structurally reduced.
• Kurt Geiger is integrating cleanly. The $360M deal (closed May 2025) is the growth engine, and only ~35% of its business is US-facing, which insulates a chunk of the acquired revenue from US tariff math even though ~80% of the assortment is China-sourced.
• The bounce off $39.71 held. Price recovered ~10% in ten sessions off the early-July low, which means the spring shelf has now been tested and defended once rather than broken.

Bear Case

• Adjusted earnings are shrinking while the multiple is not. Q1 adjusted EPS of $0.45 was down from $0.60; the FY26 adjusted guide of $2.00–$2.10 sits below 2025. The $1.00 GAAP EPS headline in Q1 carried a one-time $55.1M pre-tax tariff-recovery benefit that does not repeat. Organic DTC grew +8.0% against the +83.8% reported figure.
• UBS put the trailing-three-month total near $1.1M against zero purchases.
• No margin of safety at spot. The 7-analyst consensus average target of ~$42.43 is below the 2026-07-16 close of $43.75; the broader 12-month average of $46.78 implies single-digit upside. The high targets ($52, $54) are outliers, and UBS anchors Neutral at $40.
• China is coming back into the sourcing mix. Roughly 30% of US imports are now China-sourced after some fall production was shifted back for logistics and quality reasons a reversal of the de-risking narrative that carried the recovery leg, and one that re-attaches the stock to tariff headlines.
• FOB pricing in the new hubs runs 10–15% above old China pricing. That is a permanent gross-margin headwind that ~10% list price increases only partially cover, and it shows up in the adjusted line, not the reported one.
• The $47.11 high failed. A 52-week high that cannot hold for more than a session, followed by a 16% drawdown to $39.71, is a supply signal.

Setup & Price Structure

Range-bound with no trend to trade. The operative box is $39.71 (2026-07-06 low) to $47.11 (mid-June marginal 52-week high), with the 2026-07-16 close of $43.75 sitting almost exactly mid-range. The stock traded $39.71 on 07-06 and $40.32 on 07-09 before recovering, which establishes the low-$40s as the defended zone and roughly $39 as the shelf below it that has held since the spring breakout. Above, $46–$47 is now proven supply: two attempts, one failure, insider sales clustered at $43.45–$45.30 across the same window. Trailing performance remains strong the stock has roughly doubled off the $22.26 April-2025 low but the marginal price action since mid-June is distribution inside a box, and the whole structure is now hostage to a print 11 calendar days out. Entering a range-bound consumer name into a binary event with consensus targets at spot is the setup this playbook is built to avoid, not to catch.

Catalyst Calendar (next 30 days)

• 2026-07-30 (confirmed): Q2 2026 earnings release before market open, conference call 8:30 a.m. ET. This is the only real catalyst in the window and it is binary. Watch: wholesale demand commentary, the tariff cost line, Kurt Geiger organic contribution, and whether the FY26 adjusted EPS guide of $2.00–$2.10 moves up (the bull thesis) or gets trimmed.
• ~2026-08-06 (est.): 10-Q filing, which will carry the segment detail on organic ex-Kurt-Geiger DTC growth that the press release typically compresses.
• Ongoing through the window: tariff-policy headlines are a live input again now that China is back to ~30% of US imports; any new duty action reprices the sourcing narrative directly.

Elapsed catalysts

• No dividend record or pay date falls inside the window (the $0.21/sh paid 2026-06-19 has passed). _(passed 30d ago)_

What Would Change Our Mind

The read flips bullish if the 2026-07-30 print delivers an FY26 adjusted-EPS guide raise above $2.10 alongside positive organic ex-Kurt-Geiger DTC growth, and price then clears and holds above $47.11 on a weekly close that would convert the failed June high into a base and re-start a trend worth sizing. It flips decisively bearish on a weekly close below $39, which loses the shelf that has held since the spring breakout and confirms the recovery leg is over rather than resting. Between those two levels there is no edge worth capital. A guide cut, or organic DTC turning negative once the acquisition anniversary is lapped, would end the story regardless of where price sits.

Correlation Notes

SHOO trades as a tariff-and-consumer-discretionary beta rather than a single-stock story. It moves with the footwear and accessories complex (SKX, CROX, DECK, WWW) on tariff headlines and on any read-through from department-store channel data, and it tracks broader discretionary rotation into and out of the retail tape. The China sourcing mix reintroduces a direct link to US-China trade policy headlines that the spring nearshoring narrative had partially severed. Kurt Geiger's UK weighting adds a modest FX and European consumer input that the legacy business did not carry. Peer prints ahead of 2026-07-30 particularly any footwear name reporting tariff-driven wholesale weakness will pre-position sentiment into the SHOO number.